Living After a Rare Cancer of the Ovary: Chronic Fatigue Quality of Life and Late Effects of Chemotherapy

  • STATUS
    Recruiting
  • End date
    Dec 26, 2021
  • participants needed
    268
  • sponsor
    Centre Francois Baclesse
Updated on 26 July 2021
cancer
carcinoma
cancer chemotherapy
testicular

Summary

While they are documented in patients in remission of testicular cancer, the sequelae of chemotherapy and the impact of the disease and its treatments on the living conditions and QoL of women in remission of rare ovarian cancer remain poorly explored.

The coordinator therefore propose a national 2-step case-control study to evaluate 1) chronic fatigue and QoL and 2) chemotherapy-related sequelae in adult patients in remission of surgery-treated TGMO or TSCS (conservative or not) supplemented with chemotherapy

Details
Condition Sex Cord-Stromal Tumor, Germ cell tumor, Malignant Non-epithelial Ovarian Tumors, Malignant Non-epithelial Ovarian Tumors, Germ Cell Tumors, Malignant Non-epithelial Ovarian Tumors, Malignant Non-epithelial Ovarian Tumors, Malignant Non-epithelial Ovarian Tumors, Malignant Non-epithelial Ovarian Tumors, Malignant Non-epithelial Ovarian Tumors, Malignant Non-epithelial Ovarian Tumors, sex cord tumour, Malignant Non-epithelial Ovarian Tumors, Malignant Non-epithelial Ovarian Tumors, Malignant Non-epithelial Ovarian Tumors, Malignant Non-epithelial Ovarian Tumors, Malignant Non-epithelial Ovarian Tumors
Treatment Self-questionnaires of living conditions and quality of life, Cardiac, pulmonary, auditory and biological assessment
Clinical Study IdentifierNCT03418844
SponsorCentre Francois Baclesse
Last Modified on26 July 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Age> 18 years
Patient with an ovarian malignant germ cell tumor (TGMO) or a stroma tumor and / or sex cords (TSCS) treated optimally
Patient who has had surgery and chemotherapy (interest group) or only a surgery (control group)
Patient in remission more than 2 years after the end of the initial treatment
Relapse authorized if remission more than 2 years after the end of the treatment
Patient with no other cancers (with the exception of basal cell skin carcinomas, in situ cancers of the breast and cervix)
Patient having signed his consent to participate

Exclusion Criteria

Pregnant or breastfeeding woman
Psychiatric pathology that may disrupt the course of the study or prevent the interpretation of results
Person deprived of liberty
Major subject to a legal protection measure or unable to express his consent
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

0/250
Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note